Literature DB >> 22879410

Retinal thickening in HLA-B27-associated acute anterior uveitis: evolution with time and association with severity of inflammatory activity.

Konstantinos Balaskas1, Pierluigi Ballabeni, Yan Guex-Crosier.   

Abstract

PURPOSE: To describe the evolution of retinal thickness in eyes affected with acute anterior uveitis (AAU) in the course of follow-up and to assess its correlation with severity of inflammatory activity in the anterior chamber.
METHODS: 72 eyes (affected and fellow eyes) of 36 patients presenting with HLA-B27-related acute anterior uveitis were included in a prospective, institutional, cohort study. Patients were followed daily until beginning of resolution of inflammatory activity and weekly thereafter. Optical coherence tomography and laser flare photometry were performed at each visit. Treatment consisted of topical corticosteroids. Main outcome measures were retinal thickness of affected eyes, difference in retinal thickness between affected and fellow eyes and their evolution in time, association between maximal retinal thickness, and initial laser flare photometry.
RESULTS: Difference in retinal thickness between affected and fellow eyes became significant on average 7 days from baseline and remained so throughout follow-up (P < 0.001). There was a steep increase in retinal thickness of affected eyes, followed by a progressive decrease after reaching a peak value. Maximal difference in retinal thickness between affected and fellow eyes was observed between 17 and 25 days from baseline and exhibited a strong, positive correlation with initial laser flare photometry values (P = 0.015).
CONCLUSIONS: Retinal thickness in eyes affected with AAU presents a steep increase over 3 to 4 weeks and then gradually decreases. Severity of inflammation at baseline predicts the amount of retinal thickening in affected eyes. A characteristic pattern of temporal response of retinal anatomy to inflammatory stimuli seems to arise.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22879410     DOI: 10.1167/iovs.12-10026

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

Review 1.  Laser flare-cell photometer: principle and significance in clinical and basic ophthalmology.

Authors:  Mitsuru Sawa
Journal:  Jpn J Ophthalmol       Date:  2016-11-25       Impact factor: 2.447

2.  Mapping diurnal changes in choroidal, Haller's and Sattler's layer thickness using 3-dimensional 1060-nm optical coherence tomography.

Authors:  Maximilian Gabriel; Marieh Esmaeelpour; Farnusch Shams-Mafi; Boris Hermann; Behrooz Zabihian; Wolfgang Drexler; Susanne Binder; Siamak Ansari-Shahrezaei
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-12       Impact factor: 3.117

3.  The Evolution of Central Retinal and Choroidal Thickness in Acute Anterior Uveitic Patients with Spondyloarthropathy.

Authors:  Zsuzsanna Szepessy; Árpád Barsi; Kinga Kránitz; Zoltán Zsolt Nagy
Journal:  J Ophthalmol       Date:  2018-08-06       Impact factor: 1.909

4.  IL23R gene confers susceptibility to ankylosing spondylitis concomitant with uveitis in a Han Chinese population.

Authors:  Hongtao Dong; Qiuming Li; Ying Zhang; Wei Tan; Zhengxuan Jiang
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

5.  A cross-sectional study of submacular thickening in intermediate uveitis and determination of treatment threshold.

Authors:  Bruno Simonazzi; Konstantinos Balaskas; Yan Guex-Crosier
Journal:  BMC Ophthalmol       Date:  2016-05-18       Impact factor: 2.209

6.  Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks.

Authors:  Murat Karkucak; Mehmet Kola; Ahmet Kalkişim; Erhan Çapkin; Ahmet Ayar; Adem Türk
Journal:  Arch Rheumatol       Date:  2020-09-04       Impact factor: 1.472

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.